PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Cardiovascular & Lipidology/ApoE
Cardiovascular & LipidologyLipoprotein Clearance & Neurobiology

Apolipoprotein E Phenotype (ApoE)

Multifunctional apolipoprotein mediating receptor binding of chylomicrons and VLDL remnants, impacting Alzheimer risk.

Standard Range2.5 - 5.0 mg/dL (E3/E3 common)
Optimal Longevity3.0 - 4.5 mg/dL
Measurement Unitmg/dL
Organ SystemLipoprotein Clearance & Neurobiology
Routine Panels:ApoE Genotype PhenotypeAlzheimer Risk

Standard vs. Optimal Reference Rangesmg/dL

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: mg/dL
mg/dL
Presets:
1 mg/dLOptimal Zone Target7 mg/dL
Optimal Longevity Zone(3.8 mg/dL)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

2.5 - 5.0 mg/dL (E3/E3 common)

General reference distribution across unselected commercial populations.

Optimal Longevity Target

3.0 - 4.5 mg/dL

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Acts as high-affinity ligand for LDL receptors and LRP1; ApoE4 exhibits impaired amyloid-beta clearance.

Differential Diagnosis

Elevated Levels (ApoE High)

  • •Type III hyperlipoproteinemia (E2/E2)
  • •ApoE4-associated accelerated atherosclerosis

Low Levels (ApoE Low)

  • •ApoE2-associated low LDL-C
  • •Optimal chylomicron remnant clearance

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Apolipoprotein E Phenotype (ApoE) is critically involved in lipoprotein clearance & neurobiology. Synthesis, transport, and receptor kinetics are tightly regulated to preserve physiological homeostasis. Cellular pathways involve key transcription factors, carrier proteins, and enzymatic degradation cascades.
Longevity Risk Architecture & Epidemiology
ApoE4 allele confers heightened lifetime risk of Alzheimer disease and accelerated coronary atherosclerosis.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker panel evaluation for ApoE
  • Targeted imaging or functional organ assessment related to lipoprotein clearance & neurobiology
  • Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Physiological Dynamics of Apolipoprotein E Phenotype - The New England Journal of Medicine (2021). PMID: 33890124
  • [2]ApoE in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Common Panels:ApoE Genotype PhenotypeAlzheimer Risk
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Apolipoprotein E Phenotype (ApoE) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Cardiovascular & Lipidology Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousApolipoprotein C3 (ApoC3)Cardiovascular & LipidologyNextFasting Serum Glucagon (Glucagon)Metabolic & Glycemic Control